In an immunocompetent syngeneic mouse model of ErbB2-induced breast cancer, we next show that carbonic anhydrase inhibitors (c) acidify the tumor microenvironment, (d) lower immune infiltration and chronic tumor inflammation, and (e) accelerate tumor growth. This evidence concerns the gene ERBB2 and breast cancer.